Results 101 to 110 of about 1,157,565 (202)

Mutation analysis of β-thalassemia in East-Western Indian population: a recent molecular approach

, 2017
Parth S Shah,1 Nidhi D Shah,2 Hari Shankar P Ray,3 Nikunj B Khatri,3 Ketan K Vaghasia,3 Rutvik J Raval,4 Sandip C Shah,3 Mandava V Rao5 1Department of Medicine, Lahey Hospital and Medical Center, Boston, MA, 2Department of Pediatrics, Nassau University ...
Khatri NB, Ray HSP, Vaghasia KK, Shah PS, Raval RJ, Shah SC, Shah ND, Rao MV   +7 more
core  

Missed Diagnosis of beta-Thalassemia Trait in Premarital Screening Due to Accompanying HbA(2)-Yialousa (HBD: c.82G > T)

, 2021
The diagnosis of beta-thalassemia (beta-that) trait is usually based on an elevated HbA(2) fraction (3.5% to 8%). Co-inheritance of a delta-globin variant along with beta-globin gene defects can interfere with the diagnosis of beta-that trait by causing ...
ÖZBAŞ, Halil, YILMAZ KESKİN, Ebru, ACAR, Öznur   +2 more
core  

Role of NESTROFT as a Screening Tool for Beta-Thalassemia Trait among Pregnant Women Attending a Tertiary Care Hospital: A Cross-Sectional Study

Global Journal of Medicine and Public Health
Background Iron deficiency and thalassemia trait are the most common causes of microcytic hypochromic anemia. Serum ferritin and hemoglobin electrophoresis are required for the diagnosis of these conditions. These investigations are costly and
Amrita Singh Chauhan1, Anil R Joshi,
doaj   +1 more source

The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent beta-thalassemia in Taiwan

, 2017
Deferasirox is a novel once-daily, oral iron chelator. The aim of this study was to evaluate the long-term efficacy and tolerability of deferasirox in Taiwanese patients with transfusion-dependent beta-thalassemia who have been treated with deferasirox ...
Chang, Hsiu-Hao;Lu, Meng-Yao;Peng, Steven Shinn-Forng;Yang, Yung-Li;Lin, Dong-Tsamn;Jou, Shiann-Tarng;Lin, Kai-Hsin, 林東燦;彭信逢;周獻堂;盧孟佑;張修豪;林凱信;楊永立   +1 more
core   +1 more source

PATTERN OF THALASSEMIAS AND OTHER HEMOGLOBINOPATHIES: A STUDY IN DISTRICT DERA ISMAIL KHAN, PAKISTAN

Gomal Journal of Medical Sciences, 2014
Background: Thalassemia is used to describe disorders with a significant decrease in the rate of synthesis of a globin chain. The term hemoglobinopathy is used to indicate those disorders with structurally abnormal hemoglobin.
Javaid Hussain, Sara Arif, Sher Zamir, Mohammad Amin Jan Mahsud, Shah Jahan   +4 more
doaj  

Curcumin Therapy Reduces Iron Overload and Oxidative Stress in Beta-Thalassemia: Findings from a Meta-Analytic Study

The risk of anemia and iron overload is a global concern in beta (β)-thalassemia. The β-thalassemia primary treatment includes blood transfusion and iron chelation therapy; however, both are associated with risks such as anemia, iron depletion,
Perpetua Modjadji, Kabelo Mokgalaboni, Wendy N. Phoswa, Sogolo L. Lebelo   +3 more
core   +1 more source

Hematological Parameters in Individuals with Beta Thalassemia Trait in South Sumatra, Indonesia. [PDF]

Anemia, 2022
Sari DP, Wahidiyat PA, Setianingsih I, Timan IS, Gatot D, Kekalih A.   +5 more
europepmc   +1 more source

Feasibility of molecular diagnosis of alpha-thalassemia in the evaluation of microcytosis

Haematologica, 1997
Microcytosis is a common hematological finding, usually related to iron deficiency or beta-thalassemia. When both of these conditions are excluded, alpha-thalassemia must be considered in the differential diagnosis.
P Sivera, A Roetto, U Mazza, C Camaschella   +3 more
doaj  

Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects. [PDF]

Front Physiol, 2022
Anastasiadi AT, Tzounakas VL, Dzieciatkowska M, Arvaniti VZ, Papageorgiou EG, Papassideri IS, Stamoulis K, D'Alessandro A, Kriebardis AG, Antonelou MH.   +9 more
europepmc   +1 more source

Frequency of anemia in individuals with beta-thalassemia trait.

The Professional Medical Journal
Objective: To determine the frequency of anemia in carriers of Beta thalassemia Study Design: Retrospective Observational study. Setting: PAEC General Hospital, Islamabad, Pakistan. Period: 1st January 2022 to 30th June 2022. Methods: In this descriptive study, 131 carriers of Beta-thalassemia trait, diagnosed by hemoglobin electrophoresis on cellulose
null Huma Abdul Shakoor, null Sundas Ali, null Masooma Raza, null Naheed Khattak, null Zahra Rashid Khan, null Fatima Babar   +5 more
openaire   +1 more source